Barten MJ - Search Results

1

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.

Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: barten mj. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.

2

Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.

Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE. Gummert JF, et al. Among authors: barten mj. J Pharmacol Exp Ther. 1999 Dec;291(3):1100-12. J Pharmacol Exp Ther. 1999. PMID: 10565830

3

Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.

Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE. Gummert JF, et al. Among authors: barten mj. Transplantation. 2000 Oct 15;70(7):1038-49. doi: 10.1097/00007890-200010150-00009. Transplantation. 2000. PMID: 11045640

4

Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure.

Van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. Van Gelder T, et al. Among authors: barten mj. J Heart Lung Transplant. 2001 Feb;20(2):160-161. doi: 10.1016/s1053-2498(00)00289-8. J Heart Lung Transplant. 2001. PMID: 11250239 No abstract available.

5

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.

van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. van Gelder T, et al. Among authors: barten mj. Ther Drug Monit. 2001 Apr;23(2):119-28. doi: 10.1097/00007691-200104000-00005. Ther Drug Monit. 2001. PMID: 11294511

6

Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.

Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE. Barten MJ, et al. J Immunol Methods. 2001 Jul 1;253(1-2):95-112. doi: 10.1016/s0022-1759(01)00369-6. J Immunol Methods. 2001. PMID: 11384672

7

Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.

Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE. Barten MJ, et al. Transpl Immunol. 2002 Jun;10(1):1-14. doi: 10.1016/s0966-3274(01)00041-7. Transpl Immunol. 2002. PMID: 12182459

8

Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.

Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE. Barten MJ, et al. Am J Transplant. 2002 Sep;2(8):719-32. doi: 10.1034/j.1600-6143.2002.20806.x. Am J Transplant. 2002. PMID: 12243493 Free article.

9

Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.

Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF. Barten MJ, et al. Transplantation. 2004 Apr 27;77(8):1154-62. doi: 10.1097/01.tp.0000120391.42712.e8. Transplantation. 2004. PMID: 15114077

10

Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.

Barten MJ, Shipkova M, Bartsch P, Dhein S, Streit F, Tarnok A, Armstrong VW, Mohr FW, Oellerich M, Gummert JF. Barten MJ, et al. Ther Drug Monit. 2005 Apr;27(2):123-31. doi: 10.1097/01.ftd.0000146874.11480.8a. Ther Drug Monit. 2005. PMID: 15795640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page